Updated 2018 NICE guideline on pharmacological treatments for people with ADHD: A critical look

Erlend Faltinsen; Morris Zwi; Xavier Castells; Christian Gluud; Erik Simonsen; Ole Jakob Storebø

doi:10.1136/bmjebm-2018-111110

Updated 2018 NICE guideline on pharmacological treatments for people with ADHD: A critical look

Erlend Faltinsen^*, Morris Zwi, Xavier Castells, Christian Gluud, Erik Simonsen, Ole Jakob Storebø

^*Kontaktforfatter

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

433 Downloads (Pure)

Originalsprog	Engelsk
Tidsskrift	BMJ Evidence-Based Medicine
Vol/bind	24
Udgave nummer	3
Sider (fra-til)	99-102
ISSN	2515-446X
DOI	https://doi.org/10.1136/bmjebm-2018-111110
Status	Udgivet - 1. jun. 2019

Dokumenter og links

10.1136/bmjebm-2018-111110

Open Access VersionAccepteret manuskript, 221 KBLicens: CC BY-NC

Citationsformater

@article{79d7bc7244d146f091050f8a66ad2d96,

title = "Updated 2018 NICE guideline on pharmacological treatments for people with ADHD: A critical look",

keywords = "clinical pharmacology, mental health",

author = "Erlend Faltinsen and Morris Zwi and Xavier Castells and Christian Gluud and Erik Simonsen and Storeb{\o}, {Ole Jakob}",

year = "2019",

month = jun,

day = "1",

doi = "10.1136/bmjebm-2018-111110",

language = "English",

volume = "24",

pages = "99--102",

journal = "BMJ Evidence-Based Medicine",

issn = "2515-446X",

publisher = "BMJ Publishing Group",

number = "3",

}

TY - JOUR

T1 - Updated 2018 NICE guideline on pharmacological treatments for people with ADHD

T2 - A critical look

AU - Faltinsen, Erlend

AU - Zwi, Morris

AU - Castells, Xavier

AU - Gluud, Christian

AU - Simonsen, Erik

AU - Storebø, Ole Jakob

PY - 2019/6/1

Y1 - 2019/6/1

KW - clinical pharmacology

KW - mental health

U2 - 10.1136/bmjebm-2018-111110

DO - 10.1136/bmjebm-2018-111110

M3 - Journal article

C2 - 30530806

AN - SCOPUS:85058386127

SN - 2515-446X

VL - 24

SP - 99

EP - 102

JO - BMJ Evidence-Based Medicine

JF - BMJ Evidence-Based Medicine

IS - 3

ER -